Shb is a recently described Src homology 2 (SH2) domain-containing adaptor protein. Here we show that Shb is expressed in lymphoid tissues, and is recruited into signaling complexes upon activation of Jurkat T cells. Grb2 binds proline-rich motifs in Shb via its SH3 domains. As a result, a number of proteins detected in anti-Shb and anti-Grb2 immunoprecipitates are shared, including phosphoproteins of 22, 36/38, 55/57 and 70 kDa. Shb-association with p22, which represents the T cell receptor associated z chain, occurs through the Shb SH2 domain. The central region of Shb binds p36/ 38. Since this interaction was inhibited by phosphotyrosine, this region of Shb is likely to contain a non-SH2 PTB (phosphotyrosine binding) domain. The Shb PTB domain was found to preferentially bind the sequence Asp-Asp-X-pTyr when incubated with a phosphopeptide library. A peptide corresponding to a phosphorylation site in 34 kDa Lnk inhibited association between Shb and p36/38. Overexpression of Shb in Jurkat cells led to increased basal phosphorylation of Shb-associated p36/ 38 and p70 proteins. Inactivation of the Shb SH2 domain by an R522K mutation resulted in a reduced stimulation of tyrosine phosphorylation of several proteins in response to CD3 crosslinking when expressed in Jurkat cells. Together, our results show three distinct domains of Shb all participate in the formulation of multimeric signaling complexes in activated T cells. These results indicate that the Shb protein functions in T cell receptor signaling.
Introduction
T-cell activation is initiated by the engagement of the T-cell receptor (TCR) (Weiss and Littman, 1994; Perlmutter et al., 1993; Chan et al., 1994) . This causes a rapid tyrosine phosphorylation of ITAM (immunoreceptor tyrosine-based activation motif) sequences on the TCR associated CD3 and z chains (Weiss and Littman, 1994) . The ITAMs are repeated sequences of YXXL separated by 6 ± 8 amino acids and their tyrosine phosphorylation generates binding sites for Src homology 2 (SH2) domains of signaling molecules, such as those of ZAP 70 (Chan et al., 1992; Hutchcroft et al., 1992) . This initiates a cascade of reactions involving the adaptor protein p36/38 (Weber et al., 1992; Gilliland et al., 1992; Sieh et al., 1994) , Lnk (Huang et al., 1995) , Grb2 (Ravichandran et al., 1993) and the signaling pathways of phospholipase C g, PI-3 kinase and MAP kinase (Ravichandran et al., 1993; Secrist et al., 1991; Thompson et al., 1992) . Eventually, a signal is propagated which induces altered gene transcription, IL-2 production, dierentiation and a modi®cation of the balance between cell proliferation and apoptosis (Weiss and Littman, 1994; Perlmutter et al., 1993) .
Shb is a recently characterized adaptor protein (Welsh et al., 1994) , with an SH2 domain in its Cterminus and proline-rich sequences in its N-terminus. The cDNA sequence contains two potential translation initiation sites, the ®rst corresponding to a protein product migrating as 66 kDa and containing ®ve proline-rich motifs (Welsh et al., 1994; Karlsson and Welsh, 1996) and the second to a product migrating as 55 kDa and containing two proline-rich motifs. The proline-rich sequences of Shb have been shown to interact with the Src homology 3 (SH3) domains of the p85 subunit of PI-3 kinase, Src tyrosine kinase and the epidermal growth factor-associated adaptor protein Eps8 (Karlsson et al., 1995) . The SH2 domain of Shb binds the autophosphorylated PDGF b-receptor and the FGF receptor-1 (Karlsson et al., 1995) . The consensus motif preferentially recognized by the SH2 domain of Shb was p YTTL (Karlsson et al., 1995) , with a strong selection for leucine in position 3 downstream from the phosphotyrosine residue. With this knowledge in mind, it seemed appropriate to test for Shbinteractions in T cells, in which the ITAMs (with paired YXXL phosphopeptide motifs) play an essential role in tyrosine kinase dependent signaling. The present data demonstrate the interactions of Shb with ITAM motifs and several other signaling components. We furthermore characterize the central part of Shb as corresponding to a phosphotyrosine binding (PTB) domain. All three regions of Shb appear signi®cant for Shb's interactions in these cells. Together, these results suggest that Shb plays an important role for T-cell signaling.
Results

Human Shb is expressed in multiple tissues and recruited into tyrosine kinase signaling in activated Jurkat cells
Northern blot analysis of multiple human tissues shows that Shb mRNA is widely expressed as two transcripts of 2.5 and 3.1 kb present in all 16 tissues analysed ( Figure 1 ). Mouse tissues contain a predominant 3.1 kb mRNA (Welsh et al., 1994) . Although the levels of expression were similar in most tissues, prostate contains slightly more and peripheral blood leukocytes somewhat less Shb mRNA (Figure 1 ). Thus, it is likely that lymphocytes express the Shb mRNA, since these cells are present in spleen, thymus and blood leukocytes.
To assess a functional role of Shb in T cell signaling, phosphotyrosine proteins present in antiShb immunoprecipitates of anti-CD3-stimulated Jurkat T cells were determined (Figure 2a ). Phosphotyrosine proteins of molecular weights 22 kDa, 36/ 38 kDa, 55/57 kDa, 70 kDa, 100 kDa and 190 kDa were all found to co-precipitate with Shb after TCR stimulation. Although these six phosphotyrosine proteins were commonly seen in the anti-Shb immunoprecipitates, their relative abundance varied between dierent experiments (see Figure 3a) . The precipitation of these products was speci®c for the Shb antibody compared with normal rabbit serum (NRS). When testing for Shb immunoreactivity, a broad band of 55 ± 59 kDa was observed which was speci®cally immunoprecipitated with the Shb antibody ( Figure  2a ). In Jurkat cell extracts, the Shb antibody recognizes in addition to the 55 ± 59 kDa Shb products present in the immunoprecipitates bands of 66, 77 and 80 kDa (see Figure 3d) . Previously, Shb isoforms of 55, 66 and 77 kDa have been described, with the 66 kDa product representing Shb initiated at the ®rst methionine codon, the 55 kDa protein Shb initiated at the second methionine codon and the 77 kDa component probably representing a posttranslationally modi®ed Shb (Karlsson and Welsh, 1996) . Major phosphotyrosine products observed in the Shb immunoprecipitates were the 55/57 kDa phosphoproteins, and next the time-course after CD3 crosslinking for the tyrosine phosphorylation of these was studied (Figure 2b ). The tyrosine phosphorylation of the 55/57 kDa products present in the Shb immunoprecipitates rapidly increased (within 30 s) and remained elevated for up to 60 min of stimulation. To assess whether these products corresponded to Shb or were Shb associated, Jurkat cell extracts from unstimulated or CD3 crosslinked cells were boiled in 1% SDS, diluted and subjected to immunoprecipitation with the Shb antibody ( Figure  2c ). The purpose of this procedure was to disrupt preexisting complexes between Shb and other proteins. Western blot analysis of anti-Shb immunoprecipitates under these conditions revealed Shb immunoreactivity corresponding to the molecular weights 55 ± 59 kDa (Figure 2c ). Probing the same blot with the phosphotyrosine antibody PY-20, revealed the absence of detectable amounts of phosphotyrosine proteins in these immunoprecipitates, suggesting that the phosphorylated 55/57 products indeed are Shbassociated. One of the supernatants after the anti-Shb immunoprecipitation in Figure 2c was transferred to a fresh tube and subjected to a second immunoprecipitation with the Shb antibody (Figure 2c ). Shb immunoreactivity was absent under these conditions, suggesting ecient precipitation of Shb in the ®rst immunoprecipitation. The results in Figure 2a and b suggest that Shb is rapidly recruited into tyrosine kinase signaling upon T cell activation, implying a functional role for Shb in this process.
Comparison of Shb and Grb2 co-immunoprecipitation of phosphotyrosine proteins
To identify the Shb-associated phosphotyrosine proteins, anti-CD3 activated Jurkat cells were lysed and proteins co-immunoprecipitated with the Shb or Grb antibodies were compared. Co-precipitated proteins were identi®ed by blotting for phosphotyrosine (Figure 3a, b) . Tyrosine phosphorylation levels increased following CD3 crosslinking including those of the anti-Shb precipitated proteins of 36/38 kDa, 55 ± 57 kDa, 70 kDa and 190 kDa. The 36/38 kDa, 55/57 and 70 kDa proteins were also immunoprecipitated using the Grb2 antibody. The immunoprecipitation of the 36/38 kDa product was more ecient with the Grb2 antibody. Shorter exposure of the ECL reaction also revealed an approximate doubling of the phosphotyrosine content of p36/38 associated with Grb2 in this experiment (results not shown). When assessing the co-immunoprecipitation of phosphotyrosine proteins in the 20 ± 30 kDa molecular weight range with the Shb and Grb2 antibodies, again similarities in the co-immunoprecipitation patterns were observed (Figure 3b ). Both the Shb and the Grb2 antibodies co-immunoprecipitated two phosphotyrosine proteins of 22 and 25 kDa solely in the CD3 activated cells. The 22 kDa product is likely to be the z chain (Chan et al., 1991) .
Similarities in the co-immunoprecipitation patterns between Shb and Grb2 suggested that the two might associate with one another. This was further investigated by testing Shb-immunoprecipitates for the presence of Grb2 (Figure 3c ). Grb2 immunoreactivity he br pl lu li sm ki pa sp th pr te ov in co pbl 3.1 -2.5 - Figure 1 Northern blot of human tissues. (a) A multiple tissue Northern blot was probed for the Shb cDNA. The positions of the 3.1 and 2.5 kb mRNAs have been indicated. The tissues are heart (he), brain (br), placenta (pl), lung (lu), liver (li), skeletal muscle (sm), kidney (ki), pancreas (pa), spleen (sp), thymus (th), prostate (pr), testis (te), ovary (ov), intestine (in), colon (co) and peripheral blood leukocytes (pbl)
was demonstrated in Shb immunoprecipitates from both unstimulated and CD3 activated Jurkat cells (Figure 3c ). The speci®city of the Shb immunoprecipitation of Grb2 was demonstrated in another experiment ( Figure 3c ). No Grb2 immunoreactivity was detected after precipitation with NRS whereas Grb2 immunoreactivity was again observed after immunoprecipitation with the anti-Shb antibody. The data suggest an association between Shb and Grb2 in Jurkat cells. The domain-interactions responsible for the association between Shb and Grb2 were investigated by performing GstGrb2 fusion protein binding experiments (Figure 3d) . A large amount of the p66 Shb component, and some of the p55 Shb isoform were found in association with the GstGrb2 fusion protein. These interactions were independent of activation of the Jurkat cells. Since the Shb antibody used here was generated by immunization with a Shb fusion protein, reactivity with the GstGrb fusion protein itself was tested (Figure 3d , bl=fusion protein not mixed with the Jurkat cell extract). No detectable reactivity with the 66 and 55 kDa components was seen. The association between GstGrb2 and p66 and p55 Shb was lost by inactivation of the Grb SH3 domains by introduction of Pro to Leu point mutations at positions 49 and 206 (Figure 3d) .
Finally, the association between Shb and the Grb2-related protein GRAP (TruÈ b et al., 1997; Feng et al., 1996) was tested by transfecting a Myc-tagged GRAP cDNA into the Jurkat cells and immunoprecipitation with the Myc antibody (Figure 3e ). The results show no detectable Shb-like reactivity in the Myc antibody immunoprecipitates of mock transfected cells, whereas the GRAP-tagged cDNA transfected cells showed Shbreactivity corresponding to the p66 Shb isoform when analysed by Western blotting. The co-immunoprecipitation of this was independent of CD3 cross-linking. Thus the data suggest that both Grb2 and GRAP are associated with Shb isoforms in the Jurkat cells, and that this association shows little or no dependence on activation of the T cell receptor.
Association of phosphotyrosine proteins with various Shb fusion proteins and identi®cation of p22 as the CD3 associated z chain
To obtain an understanding for the mechanisms behind the association of Jurkat cell phosphotyrosine proteins were unstimulated (7) or stimulated by CD3 crosslinking for 2 min (+) before lysis and immunopreicipitation using normal rabbit serum (NRS) or the Shb antibody (Shb i.p.) . The immunoprecipitates were electrophoresed on 9% acrylamide/0.24% Bis gels before Western transfer and incubation with the phosphotyrosine antibody PY-20. The blot has been divided into subsections to visualize the dierent phosphotyrosine proteins since these required dierent ECL exposure times. Shb immunoreactivity in the NRS and Shb immunoprecipitates is also shown. The molecular weight standards and IgG heavy chain (IgGHC) are indicated to the left and the phosphotyrosine products to the right. (b) Jurkat cells (10 7 ) were stimulated for the time points indicated by CD3 cross-linking, lysed and immunoprecipitated using the Shb antibody. The immunoprecipitates were subjected to Western blotting using the phosphotyrosine antibody PY-20. The reactivity with p55/57 kDa doublet is shown. (c) Jurkat cells (10 7 ) without treatment (7) or stimulated for 2 min with the CD3 crosslinking antibody (+) were lysed, nuclei pelleted, and the supernatants boiled for 2 min in 1% SDS. The samples were then diluted tenfold in lysis buer and Shb was then immunoprecipitated. The supernatant after immunoprecipitation from the untreated lysate (7) (GSTp55DSH2), one major product from stimulated cells was observed; the p36/38 doublet. The association of this phosphotyrosine product was completely blocked by 20 mM phosphotyrosine. The p55 Shb product produced in the pET system bound the 22, 36/38, and 190 kDa proteins in a CD3 receptor stimulation-and phosphorylation-dependent manner. In addition to these products, small amounts of a 70 kDa phosphotyrosine protein was also found to associate with the p55 Shb protein. Although weak in this experiment, the association of the 70 kDa component to p55 Shb was strong in other experiments (see Figure 5b ). The production of p66 Shb in the pET system was inecient, and thus the corresponding experiments using this Shb isoform could not be carried out. The PY-20 phosphotyrosine antibody showed considerable background reactivity with the GSTSH2 fusion protein (seen as a broad band of 36 kDa), the GSTp55DSH2 fusion protein and its proteolytic degradation products (72 kDa and smaller) and the p55 Shb (as 62 kDa protein due to the presence of pET-derived sequences). (7) or stimulated by CD3 crosslinking (+) were lysed and immunoprecipitated using the Shb or Grb2 antibodies. The immunoprecipitates were electrophoresed on 9% polyacrylamide/0.24% Bis SDS-gels prior to transfer onto Immobilon ®lters. The ®lters were incubated with the PY-20 antibody and a secondary goat anti mouse-HRP antibody before ECL. In parallel, cell extracts (cell extr, 10 6 cells) were analysed. Molecular weight markers are indicated to the left and p36/38 to the right. (b) Phosphotyrosine proteins associated with Shb and Grb2 in the 20 ± 30 kDa molecular weight range. Cells were treated and analysed as in a. The position for the 21 kDa molecular weight marker and IgG light chain are indicated. (c) Shb co-immunoprecipitation of Grb2. Cell extracts (extr, 10 6 cells) or Shb immunoprecipitates (shb i.p., 2610 7 cells) from untreated (7) CD3 crosslinked (+) cells were subjected to SDS-gel electrophoresis on 12% polyacrylamide/ 0.32% Bis gels prior to Western transfer. The blot was incubated with the Grb2 antibody followed by an incubation with protein A/G HRP prior to ECL. In another experiment (two right lanes), the anti-Shb immunoprecipitation was compared with precipitation using normal rabbit serum (NRS). The position of Grb2 is indicated. (d) Binding of p66 and p66 Shb to wild-type or SH3 domain inactivated (mut 49/206) GstGrb2. Cell extracts (10 7 cells) from untreated (7) or CD3 crosslinked (+) cells were incubated with the fusion proteins and subjected to Western blotting using the Shb-antibody preblocked with 1 mg/ml GstGrb2. Blotting of fusion protein not mixed with extract is shown (bl) as well as an aliquot (extr, 10 6 cells) of the initial cell extract. The positions of p55, 66 and 77 Shb are indicated. (e) Association between Shb and Myc-tagged GRAP. Cells were mock transfected or transfected with the myc-tagged GRAP construct before lysis and immunoprecipitation using the Myc antibody. The samples were analysed by Western blotting using the Shb antibody. Untreated cells (7) To identify the nature of p22, blots were probed with a CD3 z antibody (Figure 4b ). The cell extracts contained a strong band of 16 kDa present in both unstimulated and CD3 crosslinked cells and a weaker 22 kDa band only present in the cell extracts from CD3 crosslinked cells. The 22 kDa product represents the tyrosine phosphorylated z chain, whereas the 16 kDa protein the unphosphorylated form of the z chain (Chan et al., 1991) . Immunoprecipitation with the Shb antibody revealed the coprecipitation of p22 only in extracts from CD3 crosslinked cells (Figure 4b) . When testing the association of the p22 z chain to immobilized, bacterially produced p55 Shb, the binding to the wild-type Shb protein was much more ecient than that to p55 Shb containing the R522K mutation (Figure 4b ) which inactivates the Shb SH2 domain (Waksman et al., 1992) (7) or CD3 cross-linked Jurkat cells (+) were lysed and mixed with the immobilized fusion proteins (10 7 cells) for 30 min on ice. In some cases, 20 mM phosphotyrosine (PY, pH=7.5) was added to the cell extract prior to mixing with the fusion proteins. The samples were electrophoresed before protein transfer and incubation with the phosphotyrosine antibody PY-20, goat anti-mouse HRP as a secondary antibody and ECL. Aliquots of the cell extracts (10 6 cells) were also electrophoresed. The positions of molecular weight markers are shown to the left, and the positions of p22, p36/38 and p190 to the right. The fusion proteins used were GST (gst), the GST-Shb SH2 domain (gstsh2), the GST-p55Shb lacking the SH2 domain (gst55shbDsh2) and the p55 Shb in pET (55shb). The PY-20 antibody showed background reactivity with the gstsh2 fusion protein (36 kDa), gst55shbDsh2 (72 kDa and smaller degradation products) and 55shb (62 kDa). The background reactivity with the fusion proteins was equal in all three lanes for each fusion protein and dominates the reactivity in the unstimulated lanes. (b) Cells from untreated (7) or CD3 crosslinked (+) Jurkat cells were lysed and immunoprecipitated (2610 7 cells) with the Shb antibody. Alternatively, aliquots of the cell extracts (10 7 cells) were mixed with immobilized, bacterially produced p55 Shb or p55 Shb carrying the R522K mutation. After washing, the samples were electrophoresed on 12% acrylamide/0.32% Bis gels before electrical transfer and incubation of the blot with the z chain and PY-20 antibodies. phosphotyrosine proteins to wild-type or R522K p55 Shb was similar (Figure 4b ). The small amount of p22 remaining bound to the R522K Shb protein could be indirect via other phosphotyrosine proteins. The results in Figure 4 suggest distinct domain interactions between Shb and phosphotyrosine proteins p22, p36/ 38, p70 and p190. p22 is the CD3 associated z chain and binds primarily to the Shb SH2 domain.
Peptide inhibition experiments
A phosphotyrosine peptide corresponding to an ITAM motif of the z chain inhibited almost completely the association of the putative z chain 22 kDa phosphotyrosine protein to the p55 bacterially produced Shb protein at 100 mM (Figure 5a ). Assessment by densitometric analysis of the association of p36/38 to the p55 Shb protein after addition of this peptide at 100 mM in the same experiment revealed a 71% inhibition of binding (results not shown). A phosphotyrosine peptide corresponding to a proposed phosphorylation site of the Lnk protein (Y297) and extending 8 amino acid residues towards the Nterminus (lnk peptide) caused a signi®cant, dosedependent inhibition of the association of the p36/38 phosphoproteins to bacterially expressed GSTp55DSH2 and p55 Shb ( Figure 5b ). However, some binding remained even at a peptide concentration of 100 mM, possibly representing indirect binding via other adaptors, such as Grb2 and GRAP (TruÈ b et al., 1997; Fukazawa et al., 1995) . A corresponding peptide (Dlnk) comprising the same six residues C-terminally, but only extending three amino acids towards the Nterminus relative to the phosphotyrosine, failed to signi®cantly in¯uence the binding of p36/38 to p55 Shb ( Figure 5b ). This latter peptide is expected to only in¯uence SH2 domain recognition, contrary to the lnk peptide which is predicted to inhibit both the SH2 and PTB domain interactions due to its N-terminal extension TruÈ b et al., 1995) . The binding of the z chain to the p55 Shb protein was not in¯uenced by the lnk peptide (results not shown). In Figure 5c , the eects of the lnk peptide on the association of p36/38 with the Grb2 SH2 domain is shown. The lnk peptide inhibited eciently the binding of p36/38 to p55 Shb, whereas that to the Grb2 SH2 domain was not aected. Background reactivity of the phosphotyrosine antibody with the GSTGrb2 SH2 domain fusion protein has been indicated. The lnk peptide inhibited at 5 mM the binding of the GSTp55DSH2 fusion protein to phosphotyrosine beads in in vitro experiments (Figure 5d ). The combined data with the lnk peptide in Figure 6b and 6d suggest that the GSTp55DSH2 fusion protein contains a PTB domain which interacts with this peptide.
PTB domain binding sequence
To assess the preferred binding sequence of the Shb PTB domain, immobilized GSTp55DSH2 fusion protein was mixed with a phosphopeptide library containing combinations of all amino acids except cysteine and tryptophane in positions 1-3 N-terminally and C-terminally relative the phosphotyrosine residue. Amino acids binding to the Shb PTB domain with a relative anity of 1.4 or higher at the dierent positions are listed in Table 1 . There was a relatively strong selection for aspartic acid in position 3 and a weaker selection for aspartic acid in position 2 upstream of the phosphotyrosine. No preferential binding (41.5) of individual amino acids in the other positions could be observed. Thus the consensus sequence for the Shb PTB domain recognition site is Asp-Asp-X-pTyr in these positions. High anity binding between the Shb PTB domain and its target sequence may require sequence speci®city in positions 74 to 77 relative the phosphotyrosine residue as well. It should be noted that the lnk peptide which contains an aspartic acid in position 3 upstream of the phosphotyrosine inhibits the association between the Shb PTB domain and p36/38.
Transfection experiments
To study the eects of Shb-overexpression on T cell receptor signaling in Jurkat cells, JMC-T Jurkat cells were transfected with the Shb cDNA by electroporation. The results demonstrated strong expression of the 66 kDa Shb isoform (Figure 6a ). This band migrated as a broad band, possibly as a doublet in these experiments. Elevated expression of the 55 kDa Shb isoform was also observed, although to a much lesser degree. Besides these two Shb isoforms, several prominent components of lower molecular weights were seen (Figure 6a ), probably representing proteolytic degradation products. The phosphotyrosine protein content of control or Shb-transfected cells was also studied (Figure 6b) . Comparison of the phosphotyrosine protein pattern assessed by Western blotting using the phosphotyrosine antibody PY-20 revealed increased phosphotyrosine contents of proteins of 36/38 and 70 kDa in the unstimulated Jurkat cells after Shb transfection. These phosphotyrosine proteins appear identical to the corresponding components that interacted with the p55 Shb protein (Figure 4a ). After stimulation by CD3 crosslinking the content of phosphotyrosine proteins was similar in the control and the Shb transfected cells (Figure 6b) .
To assess the eects of the Shb SH2 domain inactivation mutation R522K on TCR dependent phosphotyrosine signaling, regular Jurkat cells were mock transfected or transfected with the mutated Shb cDNA by electroporation (Figure 6c) . A moderate increase in the contents of the p66 and the p55 Shb proteins was observed. When the blot was probed for phosphotyrosine content, the mock transfected cells displayed increased phosphotyrosine contents of several proteins after TCR stimulation The GST55ShbDSH2 fusion protein was mixed with the phosphopeptide library GAXXXpYXXXAKKK (with X any amino acid except C and W) and preferential binding at the dierent positions was determined as previously reported (Songyang et al., 1994) . (Figure 6d ). These were of molecular weights 36/38, 66, 70 and 100 kDa. In the Jurkat cells transfected with the R522K mutated Shb cDNA the increase in tyrosine phosphorylation of several of these in response to CD3 crosslinking was diminished, especially for those of molecular weights of 36/38, 66 and 100 kDa (Figure 6d ). To further address a role of Shb for TCR signaling, another Shb construct which was entirely deleted of sequences coding for the SH2 domain was transfected into Jurkat cells, and the tyrosine phosphorylation in response to CD3 crosslinking determined ( Figure 6e) . As in the case of the R522K mutated Shb cDNA, Jurkat cells transfected with the Shb cDNA construct lacking the entire SH2 domain (ShbDSH2) displayed decreased tyrosine phosphorylation of the 36/38, 66 and 100 kDa phosphoproteins in response to TCR stimulation. The combined data in Figure 6 suggest that Shb plays a role for TCR dependent signaling and complex formation of phosphotyrosine proteins.
Transfection of Jurkat cells with the R522K mutated Shb cDNA and subsequent clonal selection for neomycin resistance yielded one clone named JurkatR522K-1 which over-expressed the 66 and 55 ± 59 kDa Shb isoforms (Figure 7) . No signs of elevated (Figure 7) , although the dierence in tyrosine phosphorylation of the 66 kDa protein could be more easily visualized by a shorter ECL exposure (results not shown). The decreased tyrosine phosphorylation of 36/38, 66 and 100 kDa proteins was also observed in the Jurkat cells transiently expressing the R522K mutated Shb (see Figure 6c ). The JurkatR522K-1 cells also displayed a decreased MAP kinase activation after CD3 stimulation compared with the Jurkat-neo cells, as assessed by decreased tyrosine phosphorylation of the MAP kinase TEY motif (Figure 7 ). MAP kinase p42 was found to be the main MAP kinase product tyrosine phosphorylated in response to CD3 activation. Probing the same blot for the presence of total p44 MAP kinase revealed equal amounts of this protein in the Jurkat-neo and JurkatR522K-1 cells (Figure 7) . Thus, the altered pattern of tyrosine phosphorylation seen in Jurkat cells expressing Shb with an inactivated SH2 domain is paralleled by decreased MAP kinase activation.
Discussion
In the present investigation we have attempted to assess the role of the adaptor protein Shb in signaling downstreams of the T cell receptor. Based on bacterial expression and transfection experiments, three Shbisoforms of 55, 66 and 77 kDa have been described previously, of which the ®rst two result from translation initiation at the second and ®rst methionine codons, respectively, whereas the 77 kDa isoform is likely to result from some post-translational modi®cation (Karlsson and Welsh, 1996) . Subsequent studies of other cell types have revealed the existence of additional Shb isoforms. In PC12 cells, for instance, three major Shb isoforms of 55, 57 and 59 kDa can be detected, all of which show elevated contents after transfection of these cells with the 2.3 kb human Shb cDNA (Karlsson and Welsh, unpublished data) . Thus the 2.3 kb Shb cDNA can generate many dierent Shb isoforms dierentially in various cells, presumably due to several translational and post-translational processes. All the observed Jurkat Shb isoforms, with the exception of the 80 kDa product, thus seem to be related to the published Shb coding sequence. The present data show that transfection of Jurkat cells with the Shb cDNA dramatically alters the relative abundance of dierent Shb isoforms compared with the untransfected cells. A possible explanation for this is Shb overexpression in itself, which could shift the processing of the Shb mRNA or proteins. Immunoprecipitation experiments reveal the rapid phosphorylation of two bands of 55 and 57 kDa which are likely to be Shb-associated proteins, since these were not detected as phosphotyrosine proteins in the Shb-immunoprecipitates performed after SDS-denaturation of the cell extracts, despite ecient immunoprecipitation of the Shb isoforms under these conditions. No evidence for tyrosine phosphorylation of p66 Shb was obtained, although this isoform was not eciently immunoprecipitated in the present experiments. In a previous study, p66 Shb (given the apparent molecular weight of 69 kDa, Karlsson et al., 1995) was immunoprecipitated, suggesting that the antibody has the ability to interact with this Shb Transfected cells were plated in multi-well dishes and selected for neomycin resistance in the presence of 1 mg/ml G418. Cells from one clone of each were stimulated for 2 min by CD3 crosslinking (+) or left unstimulated (7), after which cell extracts were electrophoresed and subjected to Western blotting as in Figure 6c isoform. However, the inecient immunoprecipitation with the Shb-antiserum is likely to have additional explanations besides a relatively low anity for native Shb isoforms. One possibility is proteolysis. This option seems probable, both considering the pattern of reactivity of the antibody with components of lower molecular weight on blots after immunoprecipitation, but also the pattern of blotting reactivity after transfection of the Shb cDNA. Another explanation that should be kept in mind is masking of antigenic epitopes on Shb by binding to other cellular components. This is particularly relevant for the interaction between Shb and p36/38, since the PTB domain which is a major part of the association between the two was also used for immunization to generate the antibody. The combined data suggest that Shb is an important adaptor linking the T cell receptor with other signaling components in Jurkat cells. The SH2 domain seems to have one major interactions; the z chain. Previous assessment of the preferred binding sequence of this SH2 domain revealed strong selection for leucine in position 3 downstream of the phosphotyrosine, making binding to ITAM motifs on the T cell receptor associated CD3 and z chains a possibility. The ITAMs are regularly spaced motifs containing two phosphotyrosine residues, each with a leucine in position three Cterminal to phosphotyrosine. The present data indeed suggest that Shb is likely to bind via its SH2 domain to the ITAM motif, although it is not clear whether only one or several of the ITAM phosphotyrosine residues is recognized. Besides the z chain, we have obtained data suggesting that p36/38 is also a binding substrate for the Shb SH2 domain based on GST-fusion protein experiments. However, the interaction of p36/38 with p55 Shb is not likely to involve the SH2 domain to any large extent, since the Dlnk peptide which contains the pYTPL sequence failed to aect the interaction between p55 Shb and p36/38 and since the SH2 domain inactivation mutation (R522K Shb) bound p36/38 almost as well as the wild-type p55 Shb.
The data suggest that the central portion of Shb is a PTB domain, and that the main phosphotyrosine protein interacting with this PTB domain is p36/38. The fusion protein containing this part of Shb, but lacking the SH2 domain, associated in a phosphotyrosine dependent manner with p36/38. The association of p36/38 to the PTB-domain fusion protein or p55 Shb was inhibited in a dose-dependent manner by a lnk peptide extending 8 amino acid residues towards the Nterminus, but not by a similar peptide extending only three residues towards the N-terminus. A long Nterminal peptide extension relative the phosphotyrosine is a characteristic feature of PTB-domain recognition TruÈ b et al., 1995) . Finally, the binding of the PTB-domain fusion protein to phosphotyrosine beads was signi®cantly inhibited at 5 mM of lnk peptide. Although the lnk peptide produced a substantial inhibition of the association of p36/38 to the Shb PTB domain, some remaining binding was observed (Figure 5b ). This could re¯ect indirect association through other adaptors which bind both p36/38 and Shb. Two such candidates are Grb2 and GRAP which interact with p36/38 via their SH2 domains (TruÈ b et al., 1997; Fukazawa et al., 1995) . The binding of these to p36/38 is not in¯uenced by the Dlnk or lnk peptides (TruÈ b et al., 1997) , and thus is retained in the conditions of Figure 5b (see Figure 5c ). The combined peptide inhibition data suggest the existence of at least two tyrosine phosphorylation sites on p36/ 38, one interacting with the Shb PTB domain and the other with the Grb2 SH2 domain.
The Grb2 and GRAP proteins associate mainly with p66 Shb. The data suggest that this interaction occurs between the SH3 domains and the proline-rich sequences of Shb. In previous work we tested the interaction between the N-terminal SH3 domain of Grb2 and the 4th and 5th proline-rich motifs of Shb (Karlsson et al., 1995) and could only detect a weak association. The most ecient association was presently observed between p66 Shb (which contains all ®ve proline-rich motifs) and full-sized Grb2 GST fusion protein containing both SH3 domains, whereas inactivation of these by site-directed mutagenesis abolished the interaction.
Transfection and expression of the Shb cDNA enhanced the basal tyrosine phosphorylation state of several proteins, mainly the 36/38 and 70 kDa proteins. The 70 kDa protein was also observed to complex with Shb in the binding experiments. The results can be interpreted to suggest that an increased Shb content facilitates complex formation in the absence of T cell receptor stimulation, and that such complex formation enhances the tyrosine phosphorylation state of some of its components. Based on the these observations, it can be speculated that Shb-mediated complex formation may play a role in the function of p36/38, previously implicated in the possible regulation of the Ras pathway (Sieh et al., 1994; Buday et al., 1994) . Although we failed to detect an increased activation of MAP kinases in Jurkat cells over-expressing the wild-type Shb (results not shown), clonally selected Jurkat cells overexpressing R522K mutated Shb displayed decreased MAP kinase activation in response to CD3 stimulation, suggesting a role for Shb in this process. Furthermore, the data suggest that the Shb-Grb2 complex may be targeted in parts to the T cell receptor by binding of the Shb SH2 domain to the z chain. This notion is supported by the failure of the R522K mutated Shb, which has an inactivated SH2 domain, to eciently bind the z chain. As a consequence of this, the pattern of Jurkat cell tyrosine phosphorylation in response to TCR activation is dramatically altered. There has been a signi®cant recent controversy about the potential role of Grb2 versus Shc in linking the z chain to Sos and the Ras pathway (Ravichandran et al., 1993; Osman et al., 1995) . It is possible that potential dierences in these studies partly derive from the participation of Shb.
In summary, our data suggest that Shb forms multimeric complexes in Jurkat cells, consisting of the z chain, Shb, p36/38 and Grb2 (or GRAP) . This complex in the activated T cell has the potential to dock other signaling components via SH2, SH3 and proline-rich domains and phosphotyrosine residues present on p36/38. Such other signaling components include the 55/57, 70, 100 and 190 kDa phosphotyrosine proteins found to interact with Shb, as well as phospholipase C g, Sos and p85 PI-3 kinase, of which the three latter have been detected in association with Grb2 and p36/38. In conclusion, our results suggest that Shb, which encompasses three distinct structural modules plays a signi®cant role in assembling proximal signaling complexes downstream of the T cell receptor.
Materials and methods
Peptides and reagents
The anity puri®ed Shb antiserum has been previously described (Karlsson and Welsh, 1996) . The Grb2 antibody (recognizes the C-terminal portion of the protein), the MAP kinase p44 (ERK1) and the CD3 z chain antibody were from Santa Cruz Biotechnology, CA. The phosphotyrosine antibody PY-20 was obtained from Transduction Laboratories and the antibody recognizing tyrosine phosphorylated MAP kinases was from New England Biolabs. An enhanced chemiluminescence system and protein A/G-peroxidase were from Pierce, Rockford, IL. The goat anti-mouse and rabbit peroxidase-conjugated antibodies were from Sigma, St Louis, MO. The peptides used were: zeta1=NQLpYNELNLGRRGEpYDVLDKR, lnk=HLRAIDNQpYTPLSQL and Dlnk=DNQpYTP-LSQL. These were synthesized by FMOC chemistry and HPLC puri®ed before use (Piccione et al., 1993) .
DNA constructs and fusion proteins
The GstGrb2 fusion protein was kindly provided by Dr M Moran. To inactivate the SH3 domains of Grb2, the SH3 domain proline residues at position 49 and 206 were converted to leucine residues by polymerase chain reactions using mutant primers to inactivate the SH3 domains. Similarly, mutant primers were used to introduce an R552K mutation of the Shb cDNA by polymerase chain reaction. The Shb cDNA from the ®rst BalI site at nucleotide 574 to the 3' end was introduced into the NotI site of pET 30a after blunt-end formation by T4 DNA polymerase. This vector produces the p55 Shb protein with additional His-tag, protein S-tag, thrombin and enterokinase sequences in the N-terminus. The p55 Shb fusion protein was produced and puri®ed on Ni-beads according to the manufacturer (Novagen). The GSTp55DSH2 domain fusion protein construct was obtained by introducing the 1.1 kb BamHI fragment from the p55 Shb-pET construct into the BamHI site of pGEX4T-2. The GSTSH2 domain fusion protein construct has previously been described (Welsh et al., 1994) . Gst fusion proteins were puri®ed by binding to glutathione-agarose beads. For the myc-tagged GRAP (TruÈ b et al., 1997) cDNA construct, an XhoI site was introduced immediately upstream of the cDNA start codon. In addition, nucleotides coding for a Myc epitope EQKLISEDL were introduced between the site encoding GRAP residue 217 and the stop codon, followed by a BamHI site. The XhoI ± BamHI fragment of the myc-tagged GRAP sequence was inserted into pSRaneo and used for transfection.
Binding experiments
Jurkat cells were cultured at 378C in 5% CO 2 in RPMI 1640 containing 10% fetal calf serum and antibiotics at a density of 10 6 cells/ml. The cells were collected by centrifugation and suspended in RPMI 1640 medium lacking serum (10 8 cells/ml) before stimulation with the SBV-3Tb CD3 antibody (Reedquist et al., 1996) at 378C for the time periods given. The cells were lysed in 50 mM Tris, pH=7.5, 150 mM NaCl, 0.5% Triton X-100, 10 mM NaF, 1 mM NaVanadate, 1 mM PMSF and 100 U/ml aprotinin (10 8 cells/ml) on ice. After 30 min, nuclei were pelleted by centrifugation at 12 000 g for 15 min at +48C, the supernatants were cleared with 0.5 ml protein A Sepharose/ml extract for 15 min before immunoprecipitated with 15 mg/ml anity puri®ed Shb antibody (Karlsson and Welsh, 1996) , or 1.5 mg/ml Grb2 antibody for 90 min on ice. Immunoprecipitates were pelleted by protein A Sepharose (50 ml). Alternatively, extracts were incubated with the immobilized fusion proteins (1 ± 5 mg) for 30 min on ice. The samples were electrophoresed on SDS-polyacrylamide gels (Laemmli, 1970) , transferred electrophoretically onto Immobilon ®lters (Millipore) and subsequently incubated with blocking solution, primary antibody, secondary antibody (goat anti-mouse HRP, goat anti-rabbit HRP or protein A/G HRP) before washing and enhanced chemiluminescence (ECL). In some experiments, SV40 T-expressing Jurkat cells (JMC-T) were transfected with the Shb cDNA inserted into pcDNA1 (Invitrogen, LaJolla, CA) or the Myc-tagged GRAP construct by electroporation 2 days before the binding experiments (Fukazawa et al., 1995) .
Northern blot analysis
The 2.3 kb human Shb cDNA was isolated and 25 ng were labeled with 32 P-dATP to 2.6610 9 d.p.m./mg using a random hexamer labeling system (Stratagene). The probe was hybridized to multiple human tissue mRNAs Northern blots (Clontech) according to recommendations by the manufacturer. The membranes were washed at 658C in 0.1% SDS+15 mM NaCl, 1.5 mM Na citrate before exposure to a storage phosphor screen for 6 h (Molecular Dynamics). Abbreviations SH2, Src Homology 2; SH3, Src Homology 3; PTB, Phosphotyrosine binding; ITAM, Immunoreceptor tyrosine-based activation motif; GST, Glutathione S-transferase; PDGF, Platelet-derived growth factor; FGF, Fibroblast growth factor; TCR, T cell receptor.
